About Us
About AJMC
About AJPB
Publications
AJMC
AJPB
Evidence-Based Diabetes Management
Evidence-Based Oncology
Supplements
Subscribe for FREE
AJMC TV
Interviews
Peer Exchange
Interactive
Interactive Tools
Featured Podcasts
Conferences
ACC 2013
AJMC Live Meeting - Oncology
AES2012
AHIP 2012
AHIP 2012 Fall Forum
AHIP Medicare Medicaid
AMCP Fall 2012
AMCP Spring 2013
ADA 2012
ASH 2012
CHEST 2012
Joslin Diabetes Innovation
NAMCP 2012
NAMCP Spring 2013
SCAI 2013
ATS 2013
News
Info for Authors
Information for Authors
Call for Papers
Submit / Track a Manuscript
Authorship Forms
Information for Reviewers
Resource Centers
Acute Coronary Syndrome
Biosimilars
Care Management
Diabetes
Evidence-Based Oncology
Pain
Value-Based Cardiology
Value-Based Insurance Design
Advertisement
Supplement
Methotrexate Therapy in the Year 2000: Outstanding Questions
Published Online:
June 01, 1999
Michael E. Weinblatt, MD
Issue: Clinical and Economic Opportunities of Anti-TNF Therapies in Rheumatoid Arthritis
SUPPLEMENT CONTENT
Participating Faculty
Introduction
Joan M. Bathon, MD
Pharmacoeconomics of Emerging Therapies for Rheumatoid Arthritis
Arthur Kavanaugh, MD
Methotrexate Therapy in the Year 2000: Outstanding Questions
Michael E. Weinblatt, MD
State-of-the-Art Combination Therapy in 1999
James R. O'Dell, MD
Assessing New Therapies for RA: Defining New Expectations for Treatment; New Therapies in Clinical Practice: Issues of Cost and Access
The Emerging Role of Anti-TNF Therapy in the Treatment of Rheumatoid Arthritis
Peter E. Lipsky, MD
Selected Abstracts
CME Quiz
Bibliography
Click for Full Issue
Advertisement
More on AJMC.COM
No Result Found
Advertisement